Kevin Whelan

Lorcaserin, a Novel Selective Human 5-Hydroxytryptamine2C Agonist: in Vitro and in Vivo Pharmacological Characterization

William Thomsen, Andrew J. Grottick, Frederique Menzaghi et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 402 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Discovery and Structure−Activity Relationship of (1<i>R</i>)-8-Chloro-2,3,4,5-tetrahydro-1-methyl-1<i>H</i>-3-benzazepine (Lorcaserin), a Selective Serotonin 5-HT_2C Receptor Agonist for the Treatment of Obesity

Brian M. Smith, Jeffrey M. Smith, James H. Tsai et al. · Journal of Medicinal Chemistry · 2007 · 202 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Discovery and SAR of new benzazepines as potent and selective 5-HT2C receptor agonists for the treatment of obesity

Brian M. Smith, Jeffrey M. Smith, James H. Tsai et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 85 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +11

Cognitive Enhancing Properties and Tolerability of Cholinergic Agents in Mice: A Comparative Study of Nicotine, Donepezil, and SIB-1553A, a Subtype-Selective Ligand for Nicotinic Acetylcholine Receptors

Bruno Bontempi, Kevin Whelan, Victoria B. Risbrough et al. · Neuropsychopharmacology · 2003 · 74 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Discovery of APD334: Design of a Clinical Stage Functional Antagonist of the Sphingosine-1-phosphate-1 Receptor

Daniel J. Buzard, Sun Hee Kim, Luis Lopez et al. · ACS Medicinal Chemistry Letters · 2014 · 72 citations · Full text

Life Sciences, Medicinal Chemistry, Pharmacology +17